Sun J et al. revealed that tumor cells resist asparaginase action by promoting amino acid metabolism through SLC1A3 expression, and the blockade of SLC1A3 improved the efficacy of asparaginase in solid tumors [40]. This evidence concerns the gene SLC1A3 and neoplasm.